Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
about
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brainCognition, language, and clinical pathological features of non-Alzheimer's dementias: an overviewNeuropathological alterations in Alzheimer diseaseGene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body diseasePassive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body diseaseNext-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseasesSelective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyReducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.UPDATE ON DEMENTIA WITH LEWY BODIES.Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies.Neuropsychology for movement disorders neurosurgery.Defining diffuse Lewy body disease. Tetrad of symptoms distinguishes illness from other dementias.Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study.Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease.Autophagy in dementias.Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia.Dementia and its implications for public health.Mechanisms of memory enhancementThe management of psychosis in movement disorder patients.Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.Rivastigmine in Parkinson's disease dementia.Role of synucleins in Alzheimer's disease.Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns.Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis.Sleep in Alzheimer's Disease - Beyond Amyloid.Proteomic identification of novel proteins in cortical lewy bodies.
P2860
Q24321216-4C252309-59ED-44FC-A185-0238A98B9CFFQ24631298-4D2687A2-BE57-4CA2-81BB-A539E4EB2DADQ27003314-D5938212-23F2-40BC-9513-5FEB0FB2D774Q28546902-4D65A673-2AFF-4E18-A9C2-BD8FAA3F39C2Q28740551-E7D22DF9-DDF7-465D-948E-AC663CD88AC1Q30578913-65B72220-33CC-4FBD-B328-1182A94DCC40Q30982993-D17DF382-EDF5-4D6B-AB2B-1894BBDE2229Q33366459-E2020A75-CD3E-4419-B259-8F04022B926EQ33613123-6A8FCDD2-9251-4F2D-A00F-4F6CB7F748FDQ33670282-45F591ED-5127-45AA-9411-B13E345B0621Q33865366-6E1F3620-98E9-4E34-8537-A5FE3E5B533CQ34306521-8DDEB350-9720-4606-BBC9-7BA7EE185A17Q34437544-1F7DB220-3A0D-4A57-A7EF-0A700B4F572DQ34450376-934DEDD2-2907-426E-BE79-11FEEDB1DAC8Q35029469-9E04403F-1801-4C64-8FD4-C07CCCA3E361Q35105765-439AC36A-AF32-43B3-928D-EB2120725B39Q35135143-67D888D1-EA14-4134-AE4F-194B5F5A4523Q35467921-A3E7E935-A21F-499D-AE51-C2769E499B06Q35609611-B23C20AA-9A3A-444D-8476-E22F70C17A59Q35624697-399A6A9C-E330-4178-8397-4CE24A8E2CAFQ36410380-609434B7-A6FB-427F-9D09-8C6B7A35190FQ36422185-F6E57153-4E26-459B-A936-DC918ED6A0F3Q36481055-B8EDCCD4-B3E4-417E-9D03-AEE402AD5FD1Q36808034-7B4518B1-A114-43B2-82CE-4C4C94CC1DDCQ37039444-A4F3EF29-4E4E-407F-837B-5CFF3FA622C4Q37232006-63CDAED4-D208-4AD1-ADE2-FEF70A27495DQ37306581-C6CC7C6A-90FA-4267-97E3-9FA566978E1CQ37347856-965CA768-E1B2-49B6-B734-D54E82465BA9Q37586721-49B96F40-4CD6-42A3-9ABA-918DA194B366Q40245982-0208E090-78DC-403E-8718-9ECE0BBF23D5Q46000518-B899B6AC-320F-4EF5-AAAE-FC742456CDF0Q47586083-4BCB4EA9-571C-4118-AD51-0C6FA1D6C24BQ48227693-0825DA1D-81AD-4D19-A74F-9D98C0A25B4F
P2860
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@ast
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@en
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@nl
type
label
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@ast
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@en
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@nl
prefLabel
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@ast
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@en
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
@nl
P1433
P1476
Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia
@en
P2093
McKeith IG
P304
P356
10.1016/S0733-8619(05)70230-9
P577
2000-11-01T00:00:00Z